NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 206 filers reported holding NEVRO CORP in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $9,400,000 | -0.3% | 54,302 | -19.8% | 1.30% | -25.5% |
| Q3 2020 | $9,429,000 | +37.2% | 67,687 | +17.7% | 1.75% | +24.6% |
| Q2 2020 | $6,871,000 | +39.0% | 57,509 | +16.3% | 1.40% | -14.2% |
| Q1 2020 | $4,944,000 | +35.8% | 49,454 | +59.7% | 1.63% | +68.9% |
| Q4 2019 | $3,641,000 | +192.9% | 30,974 | +114.3% | 0.97% | +138.5% |
| Q3 2019 | $1,243,000 | +48.2% | 14,455 | +7.8% | 0.40% | +36.4% |
| Q1 2019 | $839,000 | -68.1% | 13,415 | -55.8% | 0.30% | -76.7% |
| Q1 2018 | $2,632,000 | +157.3% | 30,370 | +169.8% | 1.27% | +98.4% |
| Q3 2017 | $1,023,000 | +83.0% | 11,255 | +88.7% | 0.64% | -19.9% |
| Q1 2017 | $559,000 | -37.5% | 5,965 | -30.4% | 0.80% | -29.3% |
| Q3 2016 | $895,000 | +21.8% | 8,570 | -14.0% | 1.13% | +2.1% |
| Q2 2016 | $735,000 | -34.5% | 9,960 | -40.1% | 1.11% | -5.9% |
| Q4 2015 | $1,122,000 | – | 16,618 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
| Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
| Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
| Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
| ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
| FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
| PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
| FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
| Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
| K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |